Skip to content
ReportWire

Breaking News & Top Current Stories – Latest US News and News from Around the World

Tag: National Center for Advancing Translational Sciences (NCATS)

Metformin reduces long COVID risk

Metformin reduces long COVID risk

June 9, 2023June 11, 2023 · Breaking News

Newswise — MINNEAPOLIS/ST. PAUL (06/09/2023) — In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the…

Read more Metformin reduces long COVID risk
Metformin reduces long COVID risk

Achieving Prevention and Health, Rather Than More Healthcare

April 23, 2023April 23, 2023 · Breaking News

Newswise — If more people have access to health insurance, we have to be sure the death rates of those with certain chronic conditions are decreasing. This is…

Read more Achieving Prevention and Health, Rather Than More Healthcare
Metformin reduces long COVID risk

“COVID rebound” is common, even in untreated patients

March 3, 2023March 4, 2023 · Breaking News

Newswise — LA JOLLA, CA—“COVID rebound,” in which evidence of the illness disappears and then returns days or weeks later, is surprisingly common—whether or not patients are given…

Read more “COVID rebound” is common, even in untreated patients
Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression

Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression

March 3, 2023March 6, 2023 · Breaking News

BYLINE: Jim Dryden Newswise — For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole (brand name Abilify) to an antidepressant…

Read more Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression
© 2026 . All rights reserved.